2 recruiting, 1 active not recruiting, 1 completed. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 2, Active not recruiting 1, Completed 1 |
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Prostate Cancer Recurrent: new trials by email Literature Review of Prostate Cancer Recurrent trials Research Report on Prostate Cancer Recurrent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer CC-1 Infusion - Prostate Cancer Recurrent | Phase 1 | Recruiting | University Hospital Tuebingen | 56 | 2022-11-11 | 2024-05-16 |
| COAST Therapy in Advanced Solid Tumors and Prostate Cancer Hydroxychloroquine, Metformin, Sirolimus, Hydroxychloroquine, Metformin, Sirolimus, Dasatanib, Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir - Prostate Cancer Recurrent, Solid Tumor, Adult | Phase 1 / Phase 2 | Recruiting | Medical University of South Carolina | 76 | 2022-03-03 | 2026-05-13 |
| Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer Epidiolex Oral Liquid Product - Prostate Cancer Recurrent, Prostate Cancer | Phase 1 | Completed | Zin W Myint | 21 | 2020-08-03 | 2025-03-05 |
| Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer Ga-68 P16-093 PET/CT scan - Prostate Cancer Recurrent, Prostate Cancer | Phase 1 / Phase 2 | Active not recruiting | Five Eleven Pharma, Inc. | 60 | 2018-05-10 | 2022-05-02 |
Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
68 Ga-P16-093 (1) · Dasatinib (1) · Hydroxychloroquine (1) · Metformin (1) · Nelfinavir (1) · Sirolimus (1)
Five Eleven Pharma, Inc. (1) · Medical University of South Carolina (1) · University Hospital Tuebingen (1) · Zin W Myint (1)
United States (3) · Germany (1)
Mark Green, PhD (1) · Zin W. Myint, MD (1)